Anna Berkenblit - Dec 31, 2021 Form 4 Insider Report for ImmunoGen, Inc. (IMGN)

Role
SVP & Chief Medical Officer
Signature
/s/ Renee Lentini, attorney in fact
Stock symbol
IMGN
Transactions as of
Dec 31, 2021
Transactions value $
$9,862
Form type
4
Date filed
1/4/2022, 03:08 PM
Previous filing
Aug 16, 2021
Next filing
Feb 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $9.86K +1.76K +1.67% $5.60 107K Dec 31, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from July 1, 2021 through December 31, 2021.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2021.